Showing results (521-530 of 574) with videos related to
Sort By:
Pageof 58
Neurology|October 20, 2010
Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal studyB Hooshmand, A Solomon, I Kåreholt, et al.Neuroscience|February 5, 2000
Alzheimer's disease presenilin-1 exon 9 deletion and L250S mutations sensitize SH-SY5Y neuroblastoma cells to hyperosmotic stress-induced apoptosisH Tanii, M Ankarcrona, F Flood, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|October 6, 2000
Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's diseaseT Dierks, V Jelic, R D Pascual-Marqui, et al.Neurology|August 15, 2001
A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate ADB Winblad, K Engedal, H Soininen, et al.Neuroreport|May 31, 1996
Abundance of the longer A beta 42 in neocortical and cerebrovascular amyloid beta deposits in Swedish familial Alzheimer's disease and Down's syndromeR N Kalaria, D L Cohen, B D Greenberg, et al.Human Genetics|August 1, 1994
Geographical distribution of haplotypes in Swedish families with Huntington's diseaseE Almqvist, S Andrew, J Theilmann, et al.The Journal of Nutrition, Health & Aging|October 6, 2010
Differences in resource use and costs of dementia care between European countries: baseline data from the ICTUS studyA Gustavsson, L Jonsson, T Rapp, et al.Dementia and Geriatric Cognitive Disorders|March 2, 2006
3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapyB Winblad, A Wimo, K Engedal, et al.Neuropathology and Applied Neurobiology|September 4, 1999
CADASIL: hereditary disease of arteries causing brain infarcts and dementiaH Kalimo, M Viitanen, K Amberla, et al.Experimental Neurology|May 19, 2001
Suppression of autoimmune neuritis in IFN-gamma receptor-deficient miceY Zhu, H G Ljunggren, E Mix, et al.Pageof 58